Skip to content

African Studies on Aging and Noncommunicable Diseases Epidemiology

African Studies on Aging and Noncommunicable Diseases Epidemiology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07427355
Acronym
ASANDE
Enrollment
1000000
Registered
2026-02-23
Start date
2025-01-15
Completion date
2030-06-01
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cardiovascular, Cardio Vascular Disease, Mortality

Brief summary

Despite the rising burden of noncommunicable diseases (NCDs), including cardiovascular diseases (CVDs), across Africa, high-quality evidence on the distribution of NCDs and their risk factors remains strikingly scarce. Many global estimates continue to rely on limited empirical data from African countries, and this persistent data gap has led major international research collaborations to underrepresent the continent. This reality highlights an urgent need for granular, context-specific, and methodologically robust data on NCDs and their determinants across Africa. The African Studies on Ageing and Noncommunicable Disease Epidemiology (ASANDE) initiative responds directly to this need by assembling harmonized, individual-level datasets from African populations, complemented by comparable data from other global regions. With recruitment underway, ASANDE seeks to quantify and compare the associations between major NCD risk factors, including cardiometabolic, behavioral, and environmental determinants, and the incidence and mortality of major NCD outcomes (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, and other NCDs) across world regions, with a particular emphasis on disparities between African populations and the rest of the global population.

Interventions

None listed

Sponsors

Alliance For Medical Research in Africa
Lead SponsorNETWORK
Institut Pasteur de Dakar
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Inclusion criteria We included cross-sectional surveys and longitudinal population-based studies providing individual-level data on established noncommunicable disease (NCD) risk factors, including body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking status, and diabetes mellitus, together with information on predefined NCD outcomes of interest (including cardiovascular diseases, cancer, chronic respiratory diseases, and other major NCDs). For longitudinal studies, prospective ascertainment of incident events and mortality was required. \-

Exclusion criteria

Participants were excluded if they were younger than 18 years at the time of assessment, had missing data on the outcome of interest, had no available information on the exposure variables (NCD risk factors), or, for longitudinal analyses, had a documented history of the respective NCD outcome at baseline.

Design outcomes

Primary

MeasureTime frameDescription
non communicable diseasesMedian follow-up of approximately 10 years across cohorts.Event rates of noncommunicable diseases (NCDs) and NCD subtypes: First fatal or non-fatal diagnosis of cardiovascular diseases (including myocardial infarction, unstable angina, coronary revascularization, ischemic or hemorrhagic stroke), cancer, chronic respiratory diseases (including chronic obstructive pulmonary disease and asthma), type 2 diabetes mellitus, chronic kidney disease, or other major NCD-related outcomes, as well as NCD-related or unclassifiable death. The type of outcome measurement varies across cohorts. NCD cases and subtypes are assessed through self-reported questionnaire information, clinical examinations, medical record validation, national hospital discharge registry data, disease-specific registries (e.g., cancer registries), causes of death registry data, or central death registries, depending on the study protocol of the respective cohort studies.

Countries

Senegal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026